ESC 365 - Angiotensin receptor-neprilysin inhibition in patients with end-stage kidney disease and refractory hypertension

ESC Professional Premium Access

Angiotensin receptor-neprilysin inhibition in patients with end-stage kidney disease and refractory hypertension

Session: Challenges with cardiovascular comorbidities

Topic: Clinical

Speaker: Doctor C. Huang (Taipei, TW)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Doctor Chin-Chou Huang

Taipei Veterans General Hospital, Taipei (Taiwan)

1 presentation

0 follower

4 more presentations in this session

At the intersection of ischemic and bleeding risk – What type-2 myocardial infarction unveils in young patient with HIV infection and uterine fibroma

Speaker: Doctor M. Iurascu-Botezatu (Bucharest, RO)

Thrombotic odyssey: navigating the challenges in a complex medical case

Speaker: Doctor A. Stoica (Bucharest, RO)

Peritoneal dialysis: is it time to move to DOACs?

Speaker: Mrs S. Burja Piko (Maribor, SI)

Systemic sclerosis/ polymyositis (SSC/ PM) overlap syndrome induced cardiomyopathy in the context of renal crisis- a diagnostic dilemma

Speaker: Doctor A. Karthik (Preston, GB)

Access the full session

Challenges with cardiovascular comorbidities

Speakers: Doctor C. Huang, Doctor M. Iurascu-Botezatu, Doctor A. Stoica, Mrs S. Burja Piko, Doctor A. Karthik

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources